2023 global peptide event overview delivery
Part1 Financing/BD Event December 2023 November 2023 September 2023 August 2023 June 2023 May 2023 Annual Highlights of Blockbuster Products
Part1 Financing/BD Event December 2023 November 2023 September 2023 August 2023 June 2023 May 2023 Annual Highlights of Blockbuster Products
The Anhui Provincial Peptide Drug Engineering Laboratory (University of Science and Technology of China), in collaboration with a team from
On December 8th, the U.S. Food and Drug Administration (FDA) approved two groundbreaking therapeutic drugs, Casgevy (developed jointly by Vertex
Continue readingCasgevy and Lyfgenia – why they are milestones and why they are just milestones
「TL;DR」: 2023 will be a challenging year for most biopharmaceutical practitioners. This year, the capital market has performed hard and
Continue readingEverything you want to know about the progress of biomedicine in 2023 is here
Eli Lilly and Company announced that its injectable Zepbound™ (tilpotide) is now available in U.S. pharmacies. Following U.S. Food and
Continue readingZepbound™ (tilpotide) injection is now available in U.S. pharmacies